The usefulness of C-reactive protein and neutrophil-to-lymphocyte ratio for predicting the outcome in hospitalized patients with liver cirrhosis

被引:57
|
作者
Kwon, Jung Hyun [1 ]
Jang, Jeong Won [2 ]
Kim, Young Woon [1 ]
Lee, Sung Won [3 ]
Nam, Soon Woo [1 ]
Jaegal, Dongwook [4 ]
Lee, Seungok [4 ]
Bae, Si Hyun [2 ]
机构
[1] Catholic Univ Korea, Dept Internal Med, Incheon St Marys Hosp, Inchon, South Korea
[2] Catholic Univ Korea, Dept Internal Med, Seoul St Marys Hosp, Seoul, South Korea
[3] Catholic Univ Korea, Dept Internal Med, Bucheon St Marys Hosp, Bucheon Si, Gyeonggi Do, South Korea
[4] Catholic Univ Korea, Incheon St Marys Hosp, Dept Lab Med, Inchon, South Korea
来源
BMC GASTROENTEROLOGY | 2015年 / 15卷
关键词
C-reactive protein; Liver cirrhosis; Infection; Neutrophil-to-lymphocyte ratio; Survival; SYSTEMIC INFLAMMATORY RESPONSE; BACTERIAL-INFECTIONS; NATURAL-HISTORY; SEPSIS; MORTALITY; INDICATOR; APOPTOSIS; SURVIVAL; FAILURE; ASCITES;
D O I
10.1186/s12876-015-0378-z
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: The role of clinical parameters such as systemic inflammatory response syndrome (SIRS) criteria in predicting the infection remains unclear in cirrhosis patients. The aim was to evaluate the usefulness of inflammatory markers including C-reactive protein (CRP) and the neutrophil-to-lymphocyte ratio (NLR) for diagnosis of infection and predicting the outcomes in hospitalized cirrhotic patients. Methods: The study included 184 cirrhotic patients consecutively hospitalized from 2011 to 2012. The presence of overt infection and survival was evaluated. CRP concentration, NLR, Model for End-Stage Liver Disease (MELD) score and the presence of SIRS were assessed. Results: The main cause of admission was uncontrolled ascites (36.4 %), followed by varix bleeding (23.9 %), and hepatic encephalopathy (13.6 %). Fifty-eight patients (31.5 %) had overt infection during hospitalization and thirty-two patients (17.4 %) expired during the follow up period (median 38 months). Ninety-two patients (52.2 %) fulfilled the SIRS criteria and among them, only 32 patients (38.5 %) had the overt infection. For diagnose of the infection, baseline CRP concentration was a significant factor compared to the presence of SIRS (odds ratio 1.202, P = 0.003). For predicting one-month short-term survival, MELD score, NLR and WBC count were significant factors but in Child-Pugh class C patients, NLR was only an independent factor. Conclusions: CRP was a significant indicator of infection in hospitalized cirrhotic patients and a NLR was a useful predictor of 1-month survival, particularly in Child-Pugh class C patients. This study suggests that the inflammatory markers such as CRP and NLR can help identify cirrhotic patients at risk of unfavorable outcomes.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Diagnostic value of procalcitonin, hypersensitive C-reactive protein and neutrophil-to-lymphocyte ratio for bloodstream infections in pediatric tumor patients
    Li, Dongmei
    Li, Jie
    Zhao, Chuanxi
    Liao, Xianglu
    Liu, Lisheng
    Xie, Li
    Shang, Wenjing
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2023, 61 (02) : 366 - 376
  • [32] C-reactive protein and the neutrophil-to-lymphocyte ratio are prognostic biomarkers in metastatic renal cell carcinoma patients treated with nivolumab
    Kotaro Suzuki
    Tomoaki Terakawa
    Junya Furukawa
    Kenichi Harada
    Nobuyuki Hinata
    Yuzo Nakano
    Masato Fujisawa
    International Journal of Clinical Oncology, 2020, 25 : 135 - 144
  • [33] Is neutrophil-to-lymphocyte ratio and C-reactive protein the prognostic role in metastatic colorectal cancer using regorafenib?
    Chen, Xinyang
    Li, Hancong
    Feng, Qingbo
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2023, 14 (01) : 472 - 473
  • [34] Strong Positive Correlation between Neutrophil-to-lymphocyte Ratio and C-reactive Protein in Early Onset Sepsis
    Ghrahani, Reni
    Yuniati, Tetty
    Judistiani, Raden Tina Dewi
    Setiabudiawan, Budi
    MAJALAH KEDOKTERAN BANDUNG-MKB-BANDUNG MEDICAL JOURNAL, 2019, 51 (04): : 246 - 252
  • [35] C-reactive protein and neutrophil-to-lymphocyte ratio as key inflammatory indicators in the diagnosis of cervical necrotizing fasciitis
    Qiu, Xiaoping
    Wang, Xin
    Jian, Shangguan
    Xu, Zhipeng
    ACTA OTO-LARYNGOLOGICA, 2024, 144 (5-6) : 384 - 391
  • [36] The effect of biological agent treatment on neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, mean platelet volume, and C-reactive protein in psoriasis patients
    An, Isa
    Ucmak, Derya
    Ozturk, Murat
    POSTEPY DERMATOLOGII I ALERGOLOGII, 2020, 37 (02): : 202 - 206
  • [37] Blood neutrophil-to-lymphocyte ratio independently predicts survival in patients with liver cirrhosis
    Biyik, Murat
    Ucar, Ramazan
    Solak, Yalcin
    Gungor, Gokhan
    Polat, Ilker
    Gaipov, Abduzhappar
    Cakir, Ozlem O.
    Ataseven, Huseyin
    Demir, Ali
    Turk, Suleyman
    Polat, Hakki
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2013, 25 (04) : 435 - 441
  • [38] Neutrophil-to-lymphocyte Ratio, Platelet-to-lymphocyte Ratio, C-reactive Protein to Albumin Ratio, and Albumin to Fibrinogen Ratio in Axial Spondyloarthritis: A Monocentric Study
    Slouma, Maroua
    Rahmouni, Safa
    Dhahri, Rim
    Gharsallah, Imen
    Metoui, Leila
    Louzir, Bassem
    CURRENT RHEUMATOLOGY REVIEWS, 2021, 17 (03) : 312 - 317
  • [39] Neutrophil-to-lymphocyte ratio and C-reactive protein–to–albumin ratio as prognostic factors for unresectable advanced or recurrent gastric cancer
    Tsutomu Namikawa
    Shigeto Shimizu
    Keiichiro Yokota
    Nobuhisa Tanioka
    Masaya Munekage
    Sunao Uemura
    Hiromichi Maeda
    Hiroyuki Kitagawa
    Michiya Kobayashi
    Kazuhiro Hanazaki
    Langenbeck's Archives of Surgery, 2022, 407 : 609 - 621
  • [40] Diagnostic Accuracy of Procalcitonin, Neutrophil-to-Lymphocyte Ratio, and C-Reactive Protein in Detection of Bacterial Infections and Prediction of Outcome in Nonneutropenic Febrile Patients with Lung Malignancy
    Ding, Shanshan
    Ma, Jun
    Song, Xingguo
    Dong, Xiaohan
    Xie, Li
    Song, Xianrang
    Liu, Lisheng
    JOURNAL OF ONCOLOGY, 2020, 2020